Bone health

Myths about osteoporosis —
References & further reading

¹ US Department of Health and Human Services. 2004. Bone health and osteoporosis: A report of the Surgeon General. URL: http://www.surgeongeneral.gov/library/bonehealth/ (accessed 07.28.2008).

² Garn, S. 1967. Nutrition and bone loss: Introductory remarks. Fed. Proc., 26 (6), 1716.

  Garn, S. 1967. Bone loss as a general phenomenon in man. Fed. Proc., 26 (6), 1729–1736. URL (no abstract available): http://www.ncbi.nlm.nih.gov/pubmed/6075908 (accessed 01.21.2009).

³ Chau, D., & Edelman, S. 2002. Osteoporosis and diabetes. Clin. Diabetes, 20 (3), 153–157. URL: http://clinical.diabetesjournals.org/cgi/content/full/20/3/153 (accessed 07.29.2008).

⁴ Kalkwarf, H. 2006. Breaking news: Forearm fractures in children and adolescents. Nutrition Today, 41 (4), 171–177. URL (abstract): http://www.nutritiontodayonline.com/pt/re/nutritiontoday/abstract.00017285-200607000-00007.htm (accessed 07.28.2008).

⁵ Munns, C., & Cowell, C. 2005. Prevention and treatment of osteoporosis in chronically ill children. J. Musculoskelet. Neuronal Interact., 5 (3), 262–272. URL (PDF): http://www.ismni.org/jmni/pdf/21/10MUNNS.pdf (accessed 07.28.2008).

⁶ Agnusdei, D., et al. 1998. Age-related decline of bone mass and intestinal calcium absorption in normal males. Calcif. Tissue Int., 63 (3), 197–201. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/9701622 (accessed 07.28.2008).

⁷ Campion, J., & Maricic, M. 2003. Osteoporosis in men. Am. Fam. Phys., 67 (7), 1521–1526. URL: http://www.aafp.org/afp/20030401/1521.html (accessed 07.28.2008).

⁸ Eliassen, A., & Hankinson, S. 2008. Endogenous hormone levels and risk of breast, endometrial, and ovarian cancers: Prospective studies. Adv. Exp. Med. Biol., 630, 148–165.URL: http://www.ncbi.nlm.nih.gov/pubmed/18637490 (accessed 08.20.2008).

  Weiss, J., et al. 2006. Risk factors for the incidence of endometrial cancer according to the aggressiveness of the disease. Am. J. Epidemiol., 164 (2), 56–62. URL: http://aje.oxfordjournals.org/cgi/content/abstract/164/1/56 (accessed 08.20.2008).

  Lippman, M., et al. 2001. Indicators of lifetime estrogen exposure: Effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J. Clin. Onc., 19 (12), 3111–3116. URL: http://jco.ascopubs.org/cgi/content/full/19/12/3111 (accessed 07.29.2008).

⁹ Abelow, B., et al. 1992. Cross-cultural association between dietary animal protein and hip fracture: A hypothesis. Calcif. Tissue Int., 50 (1), 14–18. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/1739864 (accessed 07.29.2008).

¹⁰ Frassetto, L., et al. 2000. Worldwide incidence of hip fracture in elderly women: Relation to consumption of animal and vegetable foods. J. Gerontol. A. Biol. Med. Sci., 55 (10), M585–M592. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/11034231 (accessed 07.29.2008).

¹¹ Fujita, T., & Fukase, M. 1992. Comparison of osteoporosis and calcium intake between Japan and the United States. Proc. Soc. Exp. Biol. Med., 200 (2), 149–152. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/1579574 (accessed 07.29.2008).

¹² Matković, V., et al. 1979. Bone status and fracture rates in two regions of Yugoslavia. Am. J. Clin. Nutr., 32 (3), 540–549. URL: http://www.ajcn.org/cgi/reprint/32/3/540 (accessed 07.29.2008).

  Chalmers, J., & Ho, K. 1970. Geographical variations in senile osteoporosis. The association with physical activity. J. Bone Joint Surg. Br., 52B (4), 667–675. URL: http://www.jbjs.org.uk/cgi/reprint/52-B/4/667 (accessed 07.29.2008).

  Luyken, R., & Luyken–Koning. 1961. Studies on the physiology of nutrition on Surinam. VII. Metabolism of calcium. Trop. Geogr. Med., 13, 46–54. URL (no abstract available): http://www.ncbi.nlm.nih.gov/pubmed/13764505 (accessed 07.29.2008).

¹³ Frassetto, L., et al. 2005. Long-term persistence of the urine calcium–lowering effect of potassium bicarbonate in postmenopausal women. J. Clin. Endocrin. Metab., 90 (2), 831–834. URL: http://jcem.endojournals.org/cgi/content/full/90/2/831 (accessed 07.29.2008).

  Bushinsky, D. 2004. Acid–base balance and bone health. In Nutrition and Bone Health, ed. M. Holick & B. Dawson–Hughes. Totawa, NJ: Humana Press.

  Brown, S., & Jaffe, R. 2000. Acid-alkaline balance and its effect on bone health. Int. J. Integr. Med., 2, (6), 7–15. URL (PDF): http://www.ionizers.org/pdf/bjaffe.pdf (accessed 07.29.2008).

¹⁴ Siris, E., et al. 2006. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: Results from the National Osteoporosis Risk Assessment (NORA). Osteoporos. Int., 17 (4), 565–574. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/16392027 (accessed 07.29.2008).

  Wainwright, S., et al. 2005. Hip fracture in women without osteoporosis. J. Clin. Endocrin. Metab., 90 (5), 2787–2793. URL: http://jcem.endojournals.org/cgi/content/full/90/5/2787 (accessed 07.29.2008).

  Siris, E., et al. 2004. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch. Intern. Med., 164 (10), 1108–1112. URL: http://archinte.ama-assn.org/cgi/content/full/164/10/1108 (accessed 07.29.2008).

¹⁵ Biewener, A. 1993. Safety factors in bone strength. Calcif. Tissue Int., 53 (Suppl. 1), S68–S74. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/8275382 (accessed 07.29.2008).

¹⁶ Brown, S. 2000. Better Bones, Better Body. Los Angeles: Keats Publishing.

¹⁷ Viapiana, O., et al. 2007. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone, 40 (4), 1073–1077. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/17240212 (accessed 07.29.2008).

  Smith, E., et al.1981. Physical activity and calcium modalities for bone mineral increase in aged women, Med. Sci. Sports Exerc., 13 (1), 60–64. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/7219137 (accessed 07.29.2008).

¹⁸ Ott, S. 2004. New treatments for brittle bones. Ann. Intern. Med., 141 (5), 406–407 [Letter]. URL (PDF): http://www.annals.org/cgi/reprint/141/5/406-c.pdf (accessed 07.29.2008).

¹⁹ Erikson, E., et al. 2002. Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone, 31 (5), 620–625. URL: http://www.jci.org/articles/view/12477578 (accessed 07.29.2008).

  Ott, S. 2001. Long-term safety of bisphosphonates. J. Clin. Endocrin. Metab., 90 (3), 1897–1899. URL: http://jcem.endojournals.org/cgi/content/full/90/3/1897 (accessed 07.29.2008).

  Chavassieux, P., et al. 1997. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J. Clin. Invest., 100 (6), 1475–1480. URL: http://www.jci.org/articles/view/119668 (accessed 07.29.2008).

²⁰ Cummings, S., et al. 1995. Risk factors for hip fracture in white women. NEJM, 332 (12), 767–774. URL: http://content.nejm.org/cgi/content/abstract/332/12/767 (accessed 07.29.2008).

²¹ Massé, P., et al. 2005. Coexistence of osteoporosis and cardiovascular disease risk factors in apparently healthy, untreated postmenopausal women. Int. J. Vitam. Nutr. Res., 75 (2), 97–106. URL (abstract): http://www.ncbi.nlm.nih.gov/pubmed/15929631 (accessed 07.29.2008).

Return to:

Myths about osteoporosis

 

Last Modified Date: 04/18/2011